Combination of ERα + ligand and histone deacetylase inhibitor for the treatment of cancer

摘要

The present embodiments relate to compositions and methods of treatment of cancer. More particularly, the present embodiments relate to the combination of an ERalpha+ ligand with an HDACi for the treatment of cancer, methods of treating cancer and pharmaceutical compositions for treating cancer.